TABLE 2.
Demographic and clinical characteristics of patients with a past PCR‐confirmed SARS‐CoV‐2 infection
| Characteristic | All patients | Positive Serology | Negative Serology | Inconclusive Serology | p Value |
|---|---|---|---|---|---|
| n = 71 (100%) | n = 50 (70%) | n = 15 (21%) | n = 6 (8%) | ||
| Age median [IQR] | 10.8 [3–15] | 10.8 [4–15] | 6.8 [2–13] | 7.2 [1–16] | 0.18 |
| Gender n (%) | |||||
| Male | 40 (56) | 28 (56) | 8 (53) | 4 (67) | 0.85 |
| Female | 31 (44) | 22 (44) | 7 (47) | 2 (33) | |
| Symptoms n (%) | 45 (63) | 33 (66) | 8 (53) | 4 (66) | 0.34 |
| Weakness | 22 (31) | 16 (32) | 5 (33) | 1 (16) | 0.83 |
| Fever | 21 (29) | 17 (34) | 3 (20) | 1 (16) | 0.2 |
| Sore throat | 13 (18) | 10 (20) | 3 (20) | 0 (0) | 0.79 |
| Smell/taste loss | 13 (18) | 10 (20) | 1 (6) | 2 (33) | 0.15 |
| Rhinorrhoea | 12 (17) | 8 (16) | 3 (20) | 1 (16) | 0.9 |
| Cough | 12 (17) | 7 (14) | 5 (33) | 0 (0) | 0.16 |
| Headache | 10 (14) | 6 (12) | 3 (20) | 1 (16) | 0.63 |
| Days since COVID‐19 infection n (%) | |||||
| 0–21 | 8 (11) | 1 (2) | 6 (40) | 1(16) | <0.001 |
| 22–59 | 24 (33) | 22 (44) | 1 (6) | 1(16) | 0.008 |
| 60–89 | 11 (15) | 10 (20) | 1 (6) | 0 (0) | 0.22 |
| 90–119 | 19 (26) | 15 (30) | 4 (26) | 0 (0) | 0.80 |
| 120+ | 9 (13) | 2 (4) | 3 (20) | 4 (67) | 0.04 |
Abbreviation: IQR, interquartile range.